Immune Defences from the Perspective of Essential Oils

Da Ma^*
*Correspondence: Da Ma, Department of Chemical Engineering, University of Miami School of Medicine, Miami, Florida, USA, Email:

Introduction

Among the new therapeutic approaches based on medicinal plants and their extracts, the application of essential oils is getting more and more attention. The spread of drug-resistant clinical isolates has increased as a result of the widespread use of synthetic and semi-synthetic antimicrobials. As a result, natural products like essential oils are being studied as potential antimicrobial resources. We compared the effects of common antimicrobials and essential oils on the microbicidal activity of human phagocytes in the context of a potential infection. These essential oils show antifungal drug-like. The data from the literature on the interactions between essential oils and the immune system are compared to our findings. This comparison would help fill in any remaining knowledge gaps regarding the bioactivity of essential oils and assist in the identification of therapeutic solutions to the antibiotic resistance that is becoming increasingly prevalent. There has been a significant rise in clinical interest in natural medicine over the past thirty years, with a focus on the widespread use of plant products in microbiology. The emergence of newer diseases and the rise in microorganism resistance to antimicrobials necessitate the urgent development of new, more potent medications.

Description

Due to their extensive biological and structural diversity, plants can serve as a one-of-a-kind and recurrent source for the development of novel antimicrobial compounds. Among the new therapeutic approaches that are based on medicinal plants and their extracts, the use of essential oils is appealing and is increasingly being investigated. In recent decades, interest in essential oils has been revived by aromatherapy, a subfield of alternative medicine that asserts that essential oils and other aromatic compounds have curative properties. Essential oils are concentrated liquids that are hydrophobic and come from the secondary metabolism of plants and have volatile aroma compounds in them. Their beneficial antimicrobial properties have only recently been recognized, despite their widespread use in traditional medicine, the fragrance industry, and food flavoring and preservation. This new trend is a result of increased research into the antimicrobial activity of essential oils and the spread of microorganisms that are resistant to conventional antimicrobial agents. Drug resistance can develop as a result of the rapid "mutation" of bacteria and yeasts, which alters cellular membrane proteins in such a way that drugs are unable to recognize them. In point of fact, the majority of bacteria are capable of altering membraneassociated macromolecules, such as the penicillin-binding proteins (PBPs) and enzymes, which are essential for the biosynthesis of the peptidoglycan, the primary component of the cell wall [1,2].

The primary targets of -lactam antibiotics are PBPs. Endo- and esolactamases, also known as transferases, are enzymes that are capable of inactivating aminoglycoside and beta-lactam antibiotics, respectively. Numerous bacteria are capable of producing a wide range of enzymes. It is possible that yeasts will develop resistance to antifungal treatments, particularly azoles, as a result of modifications to the efflux pump or a significant decrease in ergosterol levels in fungal cellular membranes (by 50%), which is no longer the target site of the drug. In addition, antibiotics used to treat pathogen microorganisms may alter the microbiome, which is essential for intestinal and overall body eubiosis, or cause severe side effects, particularly in patients undergoing prolonged therapeutic treatment. By promoting dysbiosis, antibiotics make the ideal conditions for pathogen microorganism colonization and subsequent infections, with the potential for recurrence. As a result, the spread of drug-resistant clinical isolates has increased with the widespread use of synthetic and semi-synthetic antimicrobials, and research is increasingly focusing on natural products like essential oils as useful antimicrobial resources. However, because microbes are unable to adapt to the heterogeneous structure of essential oils, the risk of antibiotic resistance is eliminated because essential oils contain hundreds of naturally active ingredients in varying proportions. Essential oils have been shown to be effective against a wide variety of microorganisms, including bacteria, fungi, parasites, and viruses, with the ability to eradicate pathogens while preserving "friendly" microbiota, according to limited and incomplete research [3,4].

However, from a clinical perspective, good antimicrobial activity alone is insufficient. In point of fact, clinical experience demonstrates that conventional antimicrobial agents' therapeutic efficacy is contingent not only on their direct effect on a specific microorganism but also on the activity of the host immune system. Similar to conventional medicines, essential oils must be evaluated for their potential impact on the host's defenses in order to identify compounds that can stimulate rather than hinder them in order to eradicate the infectious agent. The interaction of some essential oils on the primary functions of human polymorphonuclear cells (PMNs) from human healthy subjects against some fungal clinical pathogens is the topic of this summary of the most recent findings from our recent studies [5].

Conclusion

Along with monocyte cells, macrophages, dendritic cells, and others, PMNs are the first line of defense in the innate immune system and play an important effector role. The effects of Mentha x piperita (Huds) var., Tea Tree Oil (Melaleuca alternifolia), and Thyme Red Oil (26.52 percent thymol chemotype) The effects of essential oils of officinalis (Sole), form rubescens (Camus), and Lamiaceae on the killing of intra-PMN yeasts (Candida albicans and C. krusei) are reported and compared to those of conventional drugs to find out how they affect the microbicidal activity of human phagocytes in the context of a potential infection. Our findings have also been compared to previous research on the interactions between essential oils and the immune system. This comparison would assist in identifying therapeutic solutions to the increasingly prevalent problem of antibiotic resistance and would help to fill any remaining knowledge gaps regarding the bioactivity of essential oils.

References

1. Madeira, Catarina, Francisco Santos, Christine Kubiak, and Jacques Demotes, et al. "Transparency and accuracy in funding investigator-initiated clinical trials: A systematic search in clinical trials databases." BMJ open 9 (2019): e023394.

Google Scholar, Crossref, Indexed at

2. Gehring, Marta, Rod S. Taylor, Marie Mellody and Brigitte Casteels, et al. "Factors influencing clinical trial site selection in Europe: The survey of attitudes towards trial sites in Europe (the SAT-EU Study)." BMJ open 3 (2013): e002957.

Google Scholar, Crossref, Indexed at

3. Fukushima, Masanori, Christopher Austin, Norihiro Sato and et al. "The Global academic research organization network: Data sharing to cure diseases and enable learning health systems." "Learn Health Syst 3 (2019): e10073.

Google Scholar, Crossref, Indexed at

4. Ueda, Rieko, Yuji Nishizaki, Yasuhiro Homma and Shoji Sanada, et al. "Importance of quality assessment in clinical research in Japan." Front Pharmacol 10 (2019): 1228.

Google Scholar, Crossref, Indexed at

5. Derjaguin, B. V. and N. V. Churaev. "Structural component of disjoining pressure." J Colloid Interface Sci 49 (1974): 249-255.

Google Scholar, Crossref, Indexed at